Added values controversies concerning randomization and additivity in clinical trials

Statistics in Medicine

Volumn 23, Issue 24, 2004, Pages 3729-3753

  Senn, Stephen ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Additivity; Clinical trails; History of statistics; Randomisation; Unit treatment interaction

Indexed keywords

PLACEBO; PROPRANOLOL; SALBUTAMOL; SALMETEROL;

ANALYSIS OF VARIANCE; ARTICLE; ASTHMA; CLINICAL PROTOCOL; CLINICAL TRIAL; COVARIANCE; DRUG RESEARCH; FISHER EXACT TEST; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; META ANALYSIS; METHODOLOGY; NONHUMAN; PREDICTION; PROBABILITY; PROGNOSIS; QUALITY OF LIFE; RANDOMIZATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; CONTROLLED CLINICAL TRIAL; FEMALE; HISTORY; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICS; SURVIVAL;

DATA INTERPRETATION, STATISTICAL; FEMALE; HISTORY, 20TH CENTURY; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS; STATISTICS; SURVIVAL ANALYSIS;

EID: 16644391425     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2074     Document Type: Article

References (77)

1. Rosenberger WF, Lachin JM. Randomization in Clinical Trials: Theory and Practice. Wiley: New York, 2002.
2. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. Wiley: Chichester, New York, 1995.
3. Neyman J. Statistical problems in agricultural experimentation. Journal of the Royal Statistical Society (Suppl.) 1935; 2:107-154.
4. Box JF, Fisher RA. The Life of a Scientist. Wiley: New York, 1978.
5. Reid C. Neyman, from Life. Springer: New York, 1982.
6. Pearson ES. In Student A Statistical Biography of William Sealy Gosset (Edited and augmented by Plackett RL with the assistance of Barnard GA). Clarendon Press: Oxford, 1990.
7. Gosset WS. Co-operation in large-scale experiments. Journal of the Royal Statistical Society (Suppl.) 1936; III 115-122.
8. Fisher RA. Co-operation in large-scale experiments. Journal of the Royal Statistical Society (Suppl.) 1936; 3 122-124.
9. Barbacki S, Fisher RA. A test of the supposed precision of systematic arrangements. Annals of Eugenics 1936; 7:189-193.
10. Wiebe GA. Variation and correlation in gain yield among 1500 wheat nursery plots. Journal of Agricultural Research 1935; 50 331-357.
11. Senn SJ. Fisher's game with the devil. Statistics in Medicine 1994; 13:217-230.
12. Atkins WRG, Fisher RA. The therapeutic use of vitamin C. Journal of the Royal Army Medical Corps 1944; 83:251-252.
13. Senn SJ. Dicing with Death. Cambridge University Press: Cambridge, 2003.
14. Bennett JH. Statistical Inference and Analysis Selected Correspondence of R.A. Fisher. Oxford University Press: Oxford, 1990.
15. Holschuh N. Randomization and design: I. In RA Fisher: An Appreciation, Fienberg SE, Hinkley DV (eds). Springer: Heidelberg, 1980; 35-45.
16. Nelder JA. A reformulation of linear models. Journal of the Royal Statistical Society A 1977; 140:48-77.
17. Fisher RA. Statistical Methods for Research Workers. In Statistical Methods, Experimental Design and Scientific Inference, Bennet JH (ed.). Oxford University: Oxford, 1925.
18. Cox DR. The interpretation of the effects of non-additivity in the Latin square. Biometrika 1958; 45:69-72.
19. Senn SJ. Cross-over Trials in Clinical Research. Wiley: Chichester, 2002.
20. van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bulletin de l'Institut International de Statistique 1960; 37:351-361.
21. Senn SJ. Consensus and controversy in pharmaceutical statistics (with discussion). The Statistician 2000; 49 135-176.
22. Keene ON. The log transformation is special. Statistics in Medicine 1995; 14:811-819.
23. Senn SJ. Author's reply to Walter and Guyatt. Drug Information Journal 2003; 37:7-10.
24. Conover WJ, Salsburg DS. Locally most powerful tests for detecting treatment effects when only a subset of patients can be expected to respond to treatment. Biometrics 1988; 44 189-196.
25. Dawid AP. Symmetry models and hypotheses for structured data layouts. Journal of the Royal Statistical Society, Series B, Methodological 1988; 50:1-34.
26. Altman DG. Comparability of randomized groups. Statistician 1985; 34:125-136.
27. Beach ML, Meier P. Choosing covariates in the analysis of clinical trials. Controlled Clinical Trials 1989; 10 161S-175S.
28. Canner PL. Covariate Adjustment of Treatment Effects in Clinical-Trials. Controlled Clinical Trials 1991; 12:359-366.
29. Senn SJ. Testing for baseline balance in clinical trials. Statistics in Medicine 1994; 13:1715-1726.
30. Senn SJ. Base logic: baseline balance in randomized clinical trials. Clinical Research and Regulatory Affairs 1995; 12 171-182.
31. Berger VW, Bears JD. When can a clinical trial be called 'randomized'? Vaccine 2003; 21:468-472.
32. Senn SJ. Covariate imbalance and random allocation in clinical trials (see comments). Statistics in Medicine 1989; 8 467-475.
33. Cumberland WG, Royall RM. Does simple random sampling provide adequate balance. Journal of the Royal Statistical Society, Series B, Methodological 1988; 50:118-124.
34. Treasure T, MacRae KD. Minimization: the platinum standard for trials? Randomization doesn't guarantee similarity of groups; minimization does. British Medical Journal 1998; 317:362-363.
35. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clinical Pharmacology and Therapeutics 1974; 15:443-453.
36. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31:103-115.
37. Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971; 58:403-417.
38. Pocock SJ. Clinical Trials. A Practical Approach. Wiley: Chichester, 1983.
39. Matthews JNS. An Introduction to Randomized Clinical Trials. Arnold: London, 2000.
40. Burman C-F. On sequential treatment allocations in clinical trials. Ph.D. Thesis, Chalmers University of Technology, Gothenburg, 1996.
41. Atkinson AC. Optimum biased coin designs for sequential clinical-trials with prognostic factors. Biometrika 1982; 69 61-67.
42. Atkinson AC. Optimum biased-coin designs for sequential treatment allocation with covariate information. Statistics in Medicine 1999; 18:1741-1752.
43. Robinson LD, Jewell NP. Some surprising results about covariate adjustment in logistic regression models. International Statistical Review 1991; 58:227-240.
44. Ford I, Norrie J, Ahmadi S. Model inconsistency, illustrated by the Cox proportional hazards model. Statistics in Medicine 1995; 14:735-746.
45. Senn SJ. Statistical Issues in Drug Development. Wiley: Chichester, 1997.
46. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7:177-188.
47. Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Statistics in Medicine 1996; 15:619-629.
48. Senn SJ. The many modes of meta. Drug Information Journal 2000; 34:535-549.
49. Longford NT. Selection bias and treatment heterogeneity in clinical trials. Statistics in Medicine 1999; 18:1467-1474.
50. Senn SJ, Auclair P. The graphical representation of clinical trials with particular reference to measurements over time. Statistics in Medicine 1990; 9:1287-1302 (published erratum appears in Statistics in Medicine 1991;10(3):487).
51. Nelder JA. The great mixed-model muddle is alive and flourishing, alas! Food Quality and Preference 1998; 9 157-159.
52. Speed FM, Hocking RR, Hackney OP. Methods of analysis of linear models with unbalanced data. Journal of the American Statistical Association 1978; 73:105-112.
53. Senn SJ. Some controversies in planning and analysing multi-centre trials. Statistics in Medicine 1998; 17 1753-1765; discussion 1799-1800.
54. Gallo P. Center-weighting issues in multicenter clinical trials. Journal of Biopharmaceutical Statistics 2001; 10 145-163.
55. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. Journal of Clinical Epidemiology 1996; 49:395-400 (see comments).
56. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41 361-372.
57. Senn SJ, Harrell Jr FE. On subgroups and grouping for significance. Journal of Clinical Epidemiology 1998; 51 1367-1368 (letter; comment).
58. Senn SJ, Harrell F. On wisdom after the event. Journal of Clinical Epidemiology 1997; 50:749-751 (see comments).
59. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. On reaching the tunnel at the end of the light. Journal of Clinical Epidemiology 1997; 50:753-755 (see comments).
60. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. Clinical versus statistical considerations in the design and analysis of clinical research. Journal of Clinical Epidemiology 1998; 51:305-307.
61. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. British Medical Journal 1998; 316:690-693 (see comments).
62. Senn SJ. Applying results of randomised trials to patients. N of 1 trials are needed. British Medical Journal 1998; 317 537-538 (letter; comment).
63. Senn SJ. Individual therapy: new dawn or false dawn. Drug Information Journal 2001; 35:1479-1494.
64. Grieve AP. The number needed to treat: a useful clinical measure or a case of the Emperor's new clothes? Pharmaceutical Statistics 2003; 2:87-102.
65. Hutton JL. Numbers needed to treat: properties and problems. Journal of the Royal Statistical Society A 2000; 163:403-419 (with comments).
66. Senn SJ. Odds ratios revisited. Evidence-Based Medicine 1998; 3:71.
67. Nelder JA, Wedderburn RWM. Generalized linear models. Journal of the Royal Statistical Society A 1972; 132:107-120.
68. McCullagh P, Nelder JA. Generalized Linear Models. Chapman & Hall: London, 1989.
69. Gail MH, Wiand S, Piantadosi S. Biased estimates of treatment effects in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 1984; 71:431-444.
70. Senn SJ. Testing for individual and population equivalence based on the proportion of similar responses. Statistics in Medicine 1997; 16:1303-1306 (letter; comment).
71. Stine RA, Heyse JF. Non-parametric estimates of overlap. Statistics in Medicine 2001; 20:215-236.
72. Lane PW, Nelder JA. Analysis of covariance and standardization as instances of prediction. Biometrics 1982; 38 613-621.
73. Glasziou PP, Irwig LM. An evidence based approach to individualising treatment. British Medical Journal 1995; 311 1356-1359.
74. Lindley DV. Decision analysis and bioequivalence trials. Statistical Science 1998; 13:136-141.
75. Senn SJ. Statistical issues in bioequivalance. Statistics in Medicine 2001; 20:2785-2799.
76. Gossett WS. Comparison between balanced and random arrangements of field plots. Biometrika 1938; 29:363-378.
77. Preece DA. Distribution of final digits in data. The Statistician 1981; 30:31-60.